Mass Spectrometric Characterization of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine N-oxidized Metabolites Bound at Cys34 of Human Serum Albumin

Overview

Journal Chem Res Toxicol

Publisher American Chemical Society

Specialty Toxicology

Date 2011 Sep 16

PMID 21916490

Citations 13

Authors

Lijuan Peng

Robert J Turesky

Affiliations

Soon will be listed here.

Abstract

2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is a heterocyclic aromatic amine that is formed during the cooking of meats and poultry. PhIP is a carcinogen in rodents and a potential human carcinogen. Several short-term biomarkers of PhIP have been established for human biomonitoring, but validated long-term biomarkers of the biologically effective dose of PhIP remain to be developed. Metabolites of PhIP have been reported to covalently bind to human serum albumin (SA), which is the most abundant protein in plasma; however, the chemical structures of PhIP-SA adducts are unknown. Cysteine(34) is one of 35 conserved Cys residues in SA across species. Thirty-four of these Cys are involved in 17 disulfide bonds. The single unpaired Cys(34) residue in SA is well-known to react with carcinogenic metabolites and toxic electrophiles. 2-Nitro-1-methyl-6-phenylimidazo[4,5-b]pyridine (NO(2)-PhIP), 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine (HONH-PhIP), and 2-nitroso-1-methyl-6-phenylimidazo[4,5-b]pyridine (NO-PhIP), three genotoxic metabolites of PhIP, were reacted with purified human SA or human plasma, and the SA adduction products, following enzymatic digestion, were separated by ultra performance liquid chromatography and characterized with a linear quadrupole ion trap mass spectrometer. The major adduct of NO(2)-PhIP was formed at the Cys(34) of SA with bond formation occurring between the sulfhydryl group of Cys and the C-2 imidazole atom of PhIP. The major adducts formed between SA and HNOH-PhIP or NO-PhIP were identified as acid-labile sulfinamide linkages at Cys(34). These PhIP-SA adducts represent a measure of bioactivation of PhIP and may serve as long-term biomarkers of the biologically effective dose of PhIP.

Citing Articles

Mode of action-based risk assessment of genotoxic carcinogens.

Hartwig A, Arand M, Epe B, Guth S, Jahnke G, Lampen A Arch Toxicol. 2020; 94(6):1787-1877.

PMID: 32542409 PMC: 7303094. DOI: 10.1007/s00204-020-02733-2.

Biomonitoring an albumin adduct of the cooked meat carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in humans.

Bellamri M, Wang Y, Yonemori K, White K, Wilkens L, Le Marchand L Carcinogenesis. 2018; 39(12):1455-1462.

PMID: 30247550 PMC: 7191085. DOI: 10.1093/carcin/bgy125.

A miRNA signature for an environmental heterocyclic amine defined by a multi-organ carcinogenicity bioassay in the rat.

Chen Y, Wang R, Dashwood W, Lohr C, Williams D, Ho E Arch Toxicol. 2017; 91(10):3415-3425.

PMID: 28289824 PMC: 5836314. DOI: 10.1007/s00204-017-1945-6.

Biomonitoring Human Albumin Adducts: The Past, the Present, and the Future.

Sabbioni G, Turesky R Chem Res Toxicol. 2016; 30(1):332-366.

PMID: 27989119 PMC: 5241710. DOI: 10.1021/acs.chemrestox.6b00366.

Mass Spectrometric Characterization of an Acid-Labile Adduct Formed with 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and Albumin in Humans.

Wang Y, Villalta P, Peng L, Dingley K, Malfatti M, Turteltaub K Chem Res Toxicol. 2016; 30(2):705-714.

PMID: 27984695 PMC: 5375106. DOI: 10.1021/acs.chemrestox.6b00426.

References

Aldini G, Regazzoni L, Orioli M, Rimoldi I, Maffei Facino R, Carini M . A tandem MS precursor-ion scan approach to identify variable covalent modification of albumin Cys34: a new tool for studying vascular carbonylation. J Mass Spectrom. 2008; 43(11):1470-81. DOI: 10.1002/jms.1419. View

Bechtold W, Willis J, Sun J, Griffith W, Reddy T . Biological markers of exposure to benzene: S-phenylcysteine in albumin. Carcinogenesis. 1992; 13(7):1217-20. DOI: 10.1093/carcin/13.7.1217. View

Sinha R . An epidemiologic approach to studying heterocyclic amines. Mutat Res. 2002; 506-507:197-204. DOI: 10.1016/s0027-5107(02)00166-5. View

Alexander J, REISTAD R, Hegstad S, Frandsen H, Ingebrigtsen K, Paulsen J . Biomarkers of exposure to heterocyclic amines: approaches to improve the exposure assessment. Food Chem Toxicol. 2002; 40(8):1131-7. DOI: 10.1016/s0278-6915(02)00053-4. View

Jones C, Sabbioni G . Identification of DNA adducts using HPLC/MS/MS following in vitro and in vivo experiments with arylamines and nitroarenes. Chem Res Toxicol. 2003; 16(10):1251-63. DOI: 10.1021/tx020064i. View

Rappaport S, Li H, Grigoryan H, Funk W, Williams E . Adductomics: characterizing exposures to reactive electrophiles. Toxicol Lett. 2011; 213(1):83-90. PMC: 4758449. DOI: 10.1016/j.toxlet.2011.04.002. View

Christodoulou J, Sadler P, Tucker A . 1H NMR of albumin in human blood plasma: drug binding and redox reactions at Cys34. FEBS Lett. 1995; 376(1-2):1-5. DOI: 10.1016/0014-5793(95)01231-2. View

Noort D, Fidder A, Hulst A . Modification of human serum albumin by acrylamide at cysteine-34: a basis for a rapid biomonitoring procedure. Arch Toxicol. 2003; 77(9):543-5. DOI: 10.1007/s00204-003-0484-5. View

Chepanoske C, Brown K, Turteltaub K, Dingley K . Characterization of a peptide adduct formed by N-acetoxy-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), a reactive intermediate of the food carcinogen PhIP. Food Chem Toxicol. 2004; 42(8):1367-72. DOI: 10.1016/j.fct.2003.11.012. View

10.

Keating G, Bogen K . Estimates of heterocyclic amine intake in the US population. J Chromatogr B Analyt Technol Biomed Life Sci. 2004; 802(1):127-33. DOI: 10.1016/j.jchromb.2003.10.047. View

11.

Bryant M, Vineis P, Skipper P, Tannenbaum S . Hemoglobin adducts of aromatic amines: associations with smoking status and type of tobacco. Proc Natl Acad Sci U S A. 1988; 85(24):9788-91. PMC: 282866. DOI: 10.1073/pnas.85.24.9788. View

12.

Men L, Wang Y . Fragmentation of the deprotonated ions of peptides containing cysteine, cysteine sulfinic acid, cysteine sulfonic acid, aspartic acid, and glutamic acid. Rapid Commun Mass Spectrom. 2006; 20(5):777-84. DOI: 10.1002/rcm.2374. View

13.

Kobayashi M, Hanaoka T, Hashimoto H, Tsugane S . 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) level in human hair as biomarkers for dietary grilled/stir-fried meat and fish intake. Mutat Res. 2005; 588(2):136-42. DOI: 10.1016/j.mrgentox.2005.09.008. View

14.

REISTAD R, Frandsen H, Grivas S, Alexander J . In vitro formation and degradation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) protein adducts. Carcinogenesis. 1994; 15(11):2547-52. DOI: 10.1093/carcin/15.11.2547. View

15.

Turesky R, Lang N, Butler M, Teitel C, Kadlubar F . Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Carcinogenesis. 1991; 12(10):1839-45. DOI: 10.1093/carcin/12.10.1839. View

16.

Dingley K, Curtis K, Nowell S, FELTON J, Lang N, Turteltaub K . DNA and protein adduct formation in the colon and blood of humans after exposure to a dietary-relevant dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Cancer Epidemiol Biomarkers Prev. 1999; 8(6):507-12. View

17.

Lynch A, Murray S, Boobis A, Davies D, Gooderham N . The measurement of MeIQx adducts with mouse haemoglobin in vitro and in vivo: implications for human dosimetry. Carcinogenesis. 1991; 12(6):1067-72. DOI: 10.1093/carcin/12.6.1067. View

18.

Westra J . A rapid and simple synthesis of reactive metabolites of carcinogenic aromatic amines in high yield. Carcinogenesis. 1981; 2(4):355-7. DOI: 10.1093/carcin/2.4.355. View

19.

Knize M, Felton J . Formation and human risk of carcinogenic heterocyclic amines formed from natural precursors in meat. Nutr Rev. 2005; 63(5):158-65. DOI: 10.1111/j.1753-4887.2005.tb00133.x. View

20.

Magagnotti C, Orsi F, Bagnati R, Celli N, Rotilio D, Fanelli R . Effect of diet on serum albumin and hemoglobin adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in humans. Int J Cancer. 2000; 88(1):1-6. DOI: 10.1002/1097-0215(20001001)88:1<1::aid-ijc1>3.0.co;2-d. View